SUN PHARMA /TARO recalls
2 notices naming SUN PHARMA /TARO as the recalling firm, since December 24, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
SUN PHARMA /TARO: Lidocaine Ointment USP
Hazard (FDA): Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).
FDAMedicines
SUN PHARMA /TARO: Ciclopirox Shampoo
Hazard (FDA): Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint
FDAMedicines